C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2006
11/22/2006	EP1724262A1 1-(2h)-isoquinolone derivative
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006	EP1723146A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
11/22/2006	EP1723143A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/22/2006	EP1723138A1 Substituted benzimidazoles and their use for inducing apoptosis
11/22/2006	EP1723137A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
11/22/2006	EP1723136A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
11/22/2006	EP1723135A1 Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors
11/22/2006	EP1723134A2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723125A1 Novel 1,2,4-benzotriazine-1,4-dioxides
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723120A1 Ion channel modulators
11/22/2006	EP1723119A1 Ion channel modulators
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1723111A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723108A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1722792A1 Selected cgrp-antagonists, method for the production and use thereof as medicaments
11/22/2006	EP1722788A2 Ion channel modulators
11/22/2006	EP1722787A1 Ion channel modulators
11/22/2006	EP1722785A1 Ion channel modulators
11/22/2006	EP1722784A2 Ion channel modulators
11/22/2006	EP1722783A2 Ion channel modulators
11/22/2006	EP1722782A2 Compounds, compositions and methods for inhibiting or treating hiv-1
11/22/2006	EP1501798A4 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1438049B1 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
11/22/2006	EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1390360B1 Crystalline form of omeprazole
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1312364B1 Gatifloxacin as cytokine production inhibitor
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867563A Novel imidazole derivatives and their use as pharmaceutical agents
11/22/2006	CN1867561A Novel triarylimidazoles
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867559A Glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors
11/22/2006	CN1867551A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
11/22/2006	CN1867547A Compounds having crth2 antagonist activity
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1867331A Thalidomide analogs as TNF-alpha modulators
11/22/2006	CN1865259A Process for preparing piperidine derivative
11/22/2006	CN1865258A Ortho-substituted aryl amides for controlling invertebrate pests
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285602C 3,6-double(3-methyl pyridine-2yl)-S-tetrazine and transition metal complex, and its preparation and uses
11/22/2006	CN1285588C Farnesyl protein transferase inhibitors
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285575C Heterocyclic thioesters and ketones
11/21/2006	US7138525 Chemical intermediates for their production such as 1-ethyl-2-pyridone-5-carboxylic acid; neuropeptide Y receptor antagonists; for treatment of cardiovascular disorders, glaucoma, and eating disorders
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138412 For therapy of thromboembolic and/or inflammatory disorders
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138363 Use of metal complex compounds as oxidation catalysts
11/21/2006	US7138361 Herbicidal heterocycles
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2220080C Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
11/21/2006	CA2199226C Process for the preparation of unsymmetrical 4,6-bis(aryloxy)pyrimidine compounds
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/16/2006	WO2006122156A2 Compounds for modulating trpv3 function
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006	WO2006120701A1 An improved process for the manufacture of rabeprazole sodium
11/16/2006	WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/16/2006	WO2006120520A1 Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120224A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	WO2006119694A1 Quinolinone carboxylic acid derivatives, the preparation and the use thereof
11/16/2006	WO2006105035A3 Muscarinic modulators
11/16/2006	WO2006088541A3 Quinoline derivatives and uses thereof
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006071130B1 A process for preparation of imatinib base
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258870 Process for producing bipyridinium compound
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258678 Novel indole derivatives
11/16/2006	US20060258676 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258675 Novel crystalline forms of gatofloxacin and processes for preparation
11/16/2006	US20060258674 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258672 Multicyclic compounds and methods of their use

1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1080